Retrospective Study
Copyright ©The Author(s) 2016.
World J Gastrointest Surg. Jun 27, 2016; 8(6): 452-460
Published online Jun 27, 2016. doi: 10.4240/wjgs.v8.i6.452
Table 3 Oncologic characteristics and perioperative outcomes of study cohort
VariablesLap (%) n = 200Converted (%) n = 25Open (%) n = 408P value
Tumor gradeWell-differentiated20 (10)3 (12)38 (9.3)0.339
Mod-differentiated173 (86.5)21 (84)349 (85.6)
Poorly-differentiated7 (3.5)1 (4)21 (5.1)
Median lesion size (cm)3.94.14.30.275
T stageT118 (9)3 (12)23 (5.6)0.151
T243 (21.5)4 (16)73 (17.9)
T3126 (63)9 (36)265 (65)
T413 (6.5)9 (36)47 (11.5)
Nodal statusN095 (47.5)10 (40)188 (46.1)0.77
N+105 (52.5)15 (60)320 (53.9)
TNM stageStage I47 (23.5)3 (12)69 (16.9)0.086
Stage II51 (25.5)4 (16)111 (27.2)
Stage III75 (37.5)9 (36)162 (39.7)
Stage IV27 (13.5)9 (36)66 (16.2)
Perineural invasion+38 (19)8 (32)90 (22.1)0.652
-162 (81)17 (68)318 (77.9)
Vascular invasion+61 (30.5)11 (44)135 (33.1)0.617
-139 (69.5)14 (56)275 (66.9)
Median lymph nodes harvested (range)14 (4-90)15 (4-55)14 (3-56)0.447
Proximal margin (cm)9.9 (0-30)10 (2-22)12 (0-39)0.004
Distal margin (cm)2.1 (1-15)1.8 (1-15)2 (1-14)0.55
CRM < 2 mm29 (14.5)5 (20)75 (18.4)0.494
Median duration of surgery (min)162147119< 0.001
Length of hospitalization7 (3-159)7 (5-16)8 (3-78)< 0.001